Effect of caerulein and endogenous cholecystokinin on urecholine-induced gastric acid and pancreatic protein secretion in dogs.
D000818:Animals; D001626:Bethanechol Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D002108:Ceruletide / Q000008:administration & dosage / Q000494:pharmacology; D002766:Cholecystokinin / Q000502:physiology*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005747:Gastric Fistula / Q000503:physiopathology; D005765:Gastrointestinal Agents / Q000494:pharmacology*; D006632:Histamine / Q000008:administration & dosage; D010179:Pancreas / Q000378:metabolism*; D010185:Pancreatic Fistula / Q000503:physiopathology; D010455:Peptides / Q000494:pharmacology*; D011506:Proteins / Q000378:metabolism*; D012636:Secretory Rate / Q000187:drug effects; D013268:Stimulation, Chemical; D013270:Stomach / Q000294:innervation; D014628:Vagotomy
D001626:Bethanechol Compounds; D005765:Gastrointestinal Agents; D010455:Peptides; D011506:Proteins; D006632:Histamine; D002108:Ceruletide; D002766:Cholecystokinin